Protara Therapeutics
Price & Volume
Stats
See moreOpen | $4.50 |
Previous Close | $4.53 |
Day Range | $4.50-$4.61 |
52W Range | $1.59-$6.87 |
Market Cap | $173.9M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.17 |
News
See moreYahoo Finance • 30 days ago
Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Yahoo Finance • last year
Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
Yahoo Finance • last year
Protara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
About
CEO | Mr. Jesse Shefferman |
Address | 345 Park Avenue South, New York, NY, United States, 10010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 28 |
